Clinical Outcomes of People With Fabry Disease - ANZDATA Registry Study

Monica S Ng; Eva Malacova; Cameron Hurst; David W Johnson; Andrew J Mallett

doi:10.1016/j.ekir.2021.06.013

Clinical Outcomes of People With Fabry Disease - ANZDATA Registry Study

Kidney Int Rep. 2021 Jun 29;6(9):2481-2485. doi: 10.1016/j.ekir.2021.06.013. eCollection 2021 Sep.

Authors

Monica S Ng^{1

2

3}, Eva Malacova^{4

5

6}, Cameron Hurst⁴, David W Johnson^{1

7

8}, Andrew J Mallett^{3

9

10}

Affiliations

¹ Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
² Kidney Health Service, Royal Brisbane and Women's Hospital, Butterfield Street, Herston, Queensland, Australia.
³ Faculty of Medicine and Institute for Molecular Biosciences, The University of Queensland, Brisbane, Australia.
⁴ QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
⁵ Faculty of Health, QUT, Brisbane, Queensland, Australia.
⁶ School of Global and Population Health, University of Western Australia, Perth, WA, Australia.
⁷ Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia.
⁸ Translational Research Institute, Brisbane, Australia.
⁹ Department of Renal Medicine, Townsville University Hospital, Townsville, Queensland, Australia.
¹⁰ College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia.

No abstract available

Keywords: Fabry disease; clinical outcomes; end-stage kidney disease; enzyme replacement therapy; kidney replacement therapy; kidney transplantation; patient outcomes; registries; risk factors; survival.